Solas, Caroline <br/><br/>
The genotypic inhibitory quotient: a predictive factor of atazanavir response in HIV-1-infected treatment-experienced patients.  [electronic resource] 

 -  Journal of acquired immune deficiency syndromes (1999)  Jun 2008 
 - 177-80 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1525-4135 
<br/><br/><label>Standard No.: </label>10.1097/QAI.0b013e318164226a  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acquired Immunodeficiency Syndrome--drug therapy<br/>Adult<br/>Atazanavir Sulfate<br/>CD4 Lymphocyte Count<br/>Drug Resistance, Viral--genetics<br/>Female<br/>Genotype<br/>HIV Protease Inhibitors--therapeutic use<br/>HIV-1--drug effects<br/>Humans<br/>Male<br/>Mutation<br/>Oligopeptides--blood<br/>Pyridines--blood